Activated Rho GTPases in Cancer-The Beginning of a New Paradigm

Pontus Aspenström1

  • 1Rudbeck Laboratory, Department of Immunology, Genetics and Pathology (IGP), Uppsala University, SE 751 85 Uppsala, Sweden. pontus.aspenstrom@igp.uu.se.

Insights

Rho GTPases, initially linked to cell structure, are now recognized as oncogenes in human cancers. Their dysregulation and mutations confirm their role in cancer progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Rho GTPases, part of the Ras superfamily, were initially associated with cytoskeletal regulation and cell motility.
  • Their direct involvement in cancer progression was debated due to a lack of clear evidence.
  • Dysregulation of Rho-GTPase pathways is frequently observed in various cancers.

Purpose of the Study:

  • To review the current understanding of Rho GTPases' roles in cancer.
  • To highlight the shift in paradigm regarding Rho GTPases from regulators of cell dynamics to oncogenes.

Main Methods:

  • Literature review of studies on Rho GTPases and cancer.
  • Analysis of findings related to Rho GTPase mutations and pathway dysregulation in tumors.

Main Results:

  • Identification of point mutants in Rho GTPases (Rac1, RhoA, Cdc42) in human tumors.
  • Confirmation that Rho GTPases can function as oncogenes in several human cancers.
  • Evidence supporting the dysregulation of Rho-regulated pathways in cancer progression.

Conclusions:

  • Rho GTPases are confirmed oncogenes in human cancers.
  • Activated Rho GTPases play significant roles in cancer development and progression.
  • Further research into Rho GTPase functions in cancer is warranted.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.4K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.8K
GTPases and their Regulation02:14

GTPases and their Regulation

3.0K
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
3.8K
Coat Assembly and GTPases01:33

Coat Assembly and GTPases

Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
4.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.3K